Safety concerns and risk management of multiple sclerosis therapies von Soelberg Sorensen, P.

Volltext

Absence of MxA induction by interferon β in patients with MS reflects complete loss of bioactivity von HESSE, D, SELLEBJERG, F, SOELBERG SORENSEN, P

Volltext

IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS von SORENSEN, P. Soelberg, HAAS, J, SELLEBJERG, F, OLSSON, T, RAVNBORG, M

Volltext

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study von Cook, S, Vermersch, P, Comi, G, Giovannoni, G, Rammohan, K, Rieckmann, P, Sørensen, P Soelberg, Hamlett, A, Miret, M, Weiner, J, Viglietta, V, Musch, B, Greenberg, SJ

Volltext

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy von SORENSEN, P. Soelberg, KOCH-HENRIKSEN, N, ROSS, C, CLEMMESEN, K. M, BENDTZEN, K

Volltext

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect von Voldsgaard, A, Bager, P, Garde, E, Åkeson, P, Leffers, AM, Madsen, CG, Kapel, C, Roepstorff, A, Thamsborg, SM, Melbye, M, Siebner, H, Søndergaard, HB, Sellebjerg, F, Sørensen, P Soelberg

Volltext

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases von Elovaara, I., Apostolski, S., Van Doorn, P., Gilhus, N. E., Hietaharju, A., Honkaniemi, J., Van Schaik, I. N., Scolding, N., Soelberg Sørensen, P., Udd, B.

Volltext

Spinal cord atrophy in anterior‐posterior direction reflects impairment in multiple sclerosis von Lundell, H., Svolgaard, O., Dogonowski, A.‐M., Romme Christensen, J., Selleberg, F., Soelberg Sørensen, P., Blinkenberg, M., Siebner, H. R., Garde, E.

Volltext

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis : A dose-finding trial von FAZEKAS, F, LUBLIN, F. D, LI, D, FREEDMAN, M. S, HARTUNG, H. P, RIECKMANN, P, SOELBERG SØRENSEN, P, MAAS-ENRIQUEZ, M, SOMMERAUER, B, HANNA, K

Volltext

Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis? von Hesse, D., Krakauer, M., Lund, H., Søndergaard, H. B., Limborg, S. J. W., Soelberg Sørensen, P., Sellebjerg, F.

Volltext

Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis von Dogonowski, A.-M., Siebner, H. R., Soelberg Sørensen, P., Paulson, O. B., Dyrby, T. B., Blinkenberg, M., Madsen, K. H.

Volltext

Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study von Moberg, J. Y., Magyari, M., Koch-Henriksen, N., Thygesen, L. C., Laursen, B., Soelberg Sørensen, P.

Volltext

Identification of new sensitive biomarkers for the in vivo response to interferon-β treatment in multiple sclerosis using DNA-array evaluation von Sellebjerg, F., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A., Soelberg Sørensen, P.

Volltext

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis von Andersen, O, Elovaara, I, Färkkilä, M, Hansen, H J, Mellgren, S I, Myhr, K-M, Sandberg-Wollheim, M, Soelberg Sørensen, P

Volltext

Gene expression analysis of interferon-β treatment in multiple sclerosis von Sellebjerg, F, Datta, P, Larsen, J, Rieneck, K, Alsing, I, Oturai, A, Svejgaard, A, Soelberg Sørensen, P, Ryder, LP

Volltext

Rethinking MS in Europe: Prioritizing integrated services for people with multiple sclerosis von Battaglia, M A, Pugliatti, M, Soelberg Sørensen, P, Tiu, C, Carrascal, P, Quoidbach, V

Volltext

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurologic... von Elovaara, I, Apostolski, S, van Doorn, P, Gilhus, N E, Hietaharju, A, Honkaniemi, J, van Schaik, I N, Scolding, N, Soelberg Sørensen, P, Udd, B

Volltext

Long-Term Prolonged-Release Fampridine Treatment and Health-Related Quality of Life Outcomes: Interim Results of the Enable Study von Nagels, G, Macdonell, R, Soelberg Sorensen, P, Pozzilli, C, Laplaud, D, de Jong, B, Silva, A.M, Nicholas, R, Gaebler, J.A, Sun, J, Agarwal, S.S

Volltext

Multiple sclerosis severity score : Using disability and disease duration to rate disease severity von ROXBURGH, R. H. S. R, SEAMAN, S. R, EDAN, G, MCDONNELL, G. V, HAWKINS, S, TROJANO, M, LIGUORI, M, COCCO, E, MARROSU, M. G, TESSER, F, LEONE, M. A, WEBER, A, MASTERMAN, T, ZIPP, F, MITERSKI, B, EPPLEN, J. T, OTURAI, A, SOELBERG SØRENSEN, P, CELIUS, E. G, TELLEZ LARA, N, MONTALBAN, X, VILLOSLADA, P, SILVA, A. M, HENSIEK, A. E, MARTA, M, LEITE, I, DUBOIS, B, RUBIO, J, BUTZKUEVEN, H, KILPATRICK, T, MYCKO, M. P, SELMAJ, K. W, RIO, M. E, SA, M, SAWCER, S. J, SALEMI, G, SAVETTIERI, G, HILLERT, J, COMPSTON, D. A. S, VUKUSIC, S, ACHITI, I, CONFAVREUX, C, COUSTANS, M, LE PAGE, E

Volltext

Analysis of an interferon-γ gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients von Dai, Y, Masterman, T, Huang, W X, Sandberg-Wollheim, M, Laaksonen, M, Harbo, H F, Oturai, A, Ryder, L P, Soelberg-Sørensen, P, Svejgaard, A, Hillert, J

Volltext